Full data on Novo Nordisk’s new amylin drug raise dosing questions - STAT
- Full data on Novo Nordisk’s new amylin drug raise dosing questions STAT
- Novo Nordisk's experimental drug results in up to 24% weight loss Reuters
- Weight loss pill set to rival injections after promising studies The Independent
- Novo’s Latest Obesity Drug Shows 24% Weight Loss in Small Trial Bloomberg.com
- New weight-loss drug is ‘better than Wegovy’ — and comes in a pill The Times